Apollo Hospitals Enterprise Limited (APOLLOHOSP) Stock Statistics & Valuation Metrics

Apollo Hospitals Enterprise Limited has a market cap or net worth of ₹1.12T. The enterprise value is ₹1.01T.

Apollo Hospitals Enterprise Limited has 143,784,650 shares outstanding. The number of shares has decreased by -2.65% in one year.

Apollo Hospitals Enterprise Limited’s return on equity (ROE) is 0.18 and return on invested capital (ROIC) is 9.61%.

The current PE Ratio of Apollo Hospitals Enterprise Limited is 71.2. Apollo Hospitals Enterprise Limited’s PEG ratio is ―.

In the last 12 months, Apollo Hospitals Enterprise Limited had revenue of 217.94B and earned 14.46B in profits. Earnings per share was 100.55.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

Apollo Hospitals Enterprise Limited pays an annual dividend of ₹10, resulting in a dividend yield of 0.24%

Apollo Hospitals Enterprise Limited upcoming earnings date is Nov 6, 2025, TBA (Confirmed).

Apollo Hospitals Enterprise Limited as a current ratio of 1.54, with Debt / Equity ratio of 95.76%

In the past 12 months, Apollo Hospitals Enterprise Limited has paid 5.34B in taxes.

Apollo Hospitals Enterprise Limited EV to EBITDA ratio is 31.62, with an EV/FCF ratio of 471.44.

Apollo Hospitals Enterprise Limited has ₹29.08B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹29.08B billion.

Gross margin is 39.98%, with operating margin of 10.39%, and net profit margin of 6.63%.

The average price target for Apollo Hospitals Enterprise Limited is ₹8,181.10, which is 11.43% higher than the current price. The consensus rating is Moderate Buy